For research use only. We do not sell to patients.
MAP855
CAS No. : 1660107-77-6
Biological Activity：MAP855 is a highly potent, selective, ATP-competitive and orally active MEK1/2 kinase inhibitor (MEK1 ERK2 cascade IC50=3 nM, pERK EC50=5 nM). MAP855 shows equipotent inhibition of wild-type and mutant MEK1/2.
Research Area：Cancer
Targets：MEK|ERK
Related Screening Libraries:Bioactive Compound Library Plus;
Related Small Molecules:Avutometinib;Cobimetinib racemate;Corynoxeine;EBI-1051;Temuterkib;CHMFL-EGFR-202;CKLF1-C27;LM22B-10;ERK5-IN-4;BI-847325;Pachymic acid;6-OAU;VX-11e;Pluripotin;2,5-Dihydroxyacetophenone;Astragaloside IV;RGB-286638;ERK1/2 inhibitor 1;Binimetinib;Longdaysin;PD0325901-O-C2-dioxolane;[Tyr8] Bradykinin;Gypenoside L
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
